Company / R&D per Share
West Pharmaceutical Services R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.03
FY2025
5-year range
$0.53 / $1.03
FY2021-FY2025
Trend
+9.3%
vs FY2024
Sector context
#71 of 108
Health Care
What the data says
At $1.03, West Pharmaceutical Services's r&d per share ranks #71 of 108 in the Health Care sector. R&D per Share has increased for 4 consecutive years, from $0.53 in FY2021 to $1.03 in FY2025.
Based on SEC 10-K filings.
1.03 in FY2025 with a 5-year CAGR of +13.6%.
Improved from $0.92 to $1.03 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +13.6%
- 10-Year CAGR
- -
Sector benchmark
#71 of 108 in Health CareTop 66% of 108This company $1.03 Sector average $2.07
▼
-50.4% below sector average
Key checks
Key Insights
- West Pharmaceutical Services's r&d per share has grown for 4 consecutive years.
- In FY2025, r&d per share increased 9.3% year-over-year.
- Ranks #71 out of 108 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.03 | +9.3% |
| FY2024 | $0.94 | +1.8% |
| FY2023 | $0.92 | +46.0% |
| FY2022 | $0.63 | +20.2% |
| FY2021 | $0.53 | -3.3% |
| FY2020 | $0.54 | +3.6% |
| FY2019 | $0.52 | -3.7% |
| FY2018 | $0.55 | +2.0% |
| FY2017 | $0.53 | +3.7% |
| FY2016 | $0.52 | -2.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026